Choi, Ik Jun <br/><br/>
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents.  [electronic resource] 

 -  Medicine  Jun 2016 
 - e4049 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000004049  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Alleles<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19--genetics<br/>Drug-Eluting Stents<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Ticlopidine--analogs & derivatives<br/>Treatment Outcome